Wong Ma-Li, O'Kirwan Fiona, Khan Nadia, Hannestad Jonas, Wu Kwok H, Elashoff David, Lawson Gregory, Gold Philip W, McCann Samuel M, Licinio Julio
Center for Pharmacogenomics, Neuropsychiatric Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1761, USA.
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14241-6. doi: 10.1073/pnas.2336220100. Epub 2003 Nov 17.
In septic shock, reversible cardiac dysfunction starts within 24 h. Myocardial depressant factors are thought to cause myocyte dysfunction, resulting in alterations of intrinsic cardiac function. Nitric oxide is a myocardial depressant factor candidate. Here we identify endotoxin-induced myocarditis (EIM) a previously uncharacterized pathophysiological entity. Features of EIM include differential patterns of inducible NO synthase (NOS2) mRNA induction in the left (LV) and right (RV) ventricles during the systemic response inflammatory syndrome (SIRS) and the presence of myocarditis with focal areas of aseptic necrosis in the RV 24 h after SIRS induction. Even though clinical data lead to the presumption of myocardial injury in sepsis, the underlying pathophysiological mechanisms have not been previously elucidated. Gene expression profiling was used to test the hypothesis of differential LV and RV responses in EIM, and revealed novel patterns of qualitative and quantitative expansion of transcription. Those genes are novel targets for drug development in SIRS and sepsis. Our results demonstrate spatial and temporal heterogeneity of myocardial responses in EIM. These findings justify the design of treatments to ameliorate tissue injury in the RV. Because the complexity of the inflammatory response increases substantially as time elapses, we suggest a stepwise and multitarget therapeutic approach for SIRS and sepsis. Our findings can help identify innate immune pathways that could become targets for immunotherapy in the treatment of disease caused by potential bioterrorism agents.
在脓毒性休克中,可逆性心脏功能障碍在24小时内开始出现。心肌抑制因子被认为可导致心肌细胞功能障碍,进而引起心脏固有功能的改变。一氧化氮是心肌抑制因子的候选物质。在此,我们确定了内毒素诱导的心肌炎(EIM),这是一种此前未被描述的病理生理实体。EIM的特征包括在全身炎症反应综合征(SIRS)期间左心室(LV)和右心室(RV)中诱导型一氧化氮合酶(NOS2)mRNA诱导的差异模式,以及在SIRS诱导后24小时RV中存在伴有无菌性坏死灶的心肌炎。尽管临床数据提示脓毒症中存在心肌损伤,但此前尚未阐明其潜在的病理生理机制。基因表达谱分析用于检验EIM中左心室和右心室反应差异的假设,并揭示了转录在定性和定量方面扩展的新模式。这些基因是SIRS和脓毒症药物研发的新靶点。我们的结果证明了EIM中心肌反应的时空异质性。这些发现为改善右心室组织损伤的治疗设计提供了依据。由于随着时间推移炎症反应的复杂性会大幅增加,我们建议针对SIRS和脓毒症采用逐步和多靶点的治疗方法。我们的发现有助于识别先天免疫途径,这些途径可能成为治疗由潜在生物恐怖主义制剂引起的疾病的免疫治疗靶点。